Flex Pharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
1,010.70
1,274.50
838.10
Cost of Goods Sold (COGS) incl. D&A
12.00
49.90
662.70
506.50
430.80
Gross Income
12.00
49.90
347.90
768.00
407.40
SG&A Expense
8,017.80
29,163.80
40,234.10
35,493.60
21,092
EBIT
8,029.80
29,213.70
39,886.20
34,725.60
20,684.60
Pretax Income
8,010.90
29,141.60
39,493.10
34,433.70
21,922.20
Consolidated Net Income
8,010.90
29,141.60
39,493.10
34,433.70
21,922.20
Net Income
8,010.90
29,141.60
39,493.10
34,433.70
21,922.20
Net Income After Extraordinaries
8,010.90
29,141.60
39,493.10
34,433.70
21,922.20
Net Income Available to Common
8,010.90
29,141.60
39,493.10
34,433.70
21,922.20
EPS (Basic)
4.57
2.08
2.43
1.99
1.22
Basic Shares Outstanding
1,753.00
14,032.90
16,234.00
17,260.60
18,016.80
EPS (Diluted)
4.57
2.08
2.43
1.99
1.22
Diluted Shares Outstanding
1,753.00
14,032.90
16,234.00
17,260.60
18,016.80
EBITDA
8,017.80
29,163.80
39,609.00
34,401.10
20,456.50
Non-Operating Interest Income
18.90
72.00
393.10
292.00
152
About Flex Pharma
View Profile
